Literature DB >> 1493731

Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis.

A van Es1, F C Henny, M P Kooistra, S Lobatto, H R Scholte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1493731     DOI： 10.1159/000421598

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  10 in total

1.  Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients.

Authors:  Y Kudoh; S Aoyama; T Torii; Q Chen; D Nagahara; H Sakata; A Nozawa
Journal:  Cardiorenal Med       Date:  2013-09-27       Impact factor: 2.041

Review 2.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

3.  Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis.

Authors:  Kristen Sgambat; Lowell Frank; Ahmad Ellini; Craig Sable; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2012-03-22       Impact factor: 3.714

4.  Alteration of energy production by the heart in CRF patients undergoing peritoneal dialysis.

Authors:  Goichi Ogimoto; Tsutomu Sakurada; Keiko Imamura; Shingo Kuboshima; Teruhiko Maeba; Kenjiro Kimura; Shigeru Owada
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

5.  Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysis.

Authors:  Kei Fukami; Sho-Ichi Yamagishi; Kazuko Sakai; Yusuke Kaida; Takeki Adachi; Ryotaro Ando; Seiya Okuda
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

6.  The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis.

Authors:  Api Chewcharat; Pol Chewcharat; Weitao Liu; Jacqueline Cellini; Elizabeth A Phipps; Jill A Melendez Young; Sagar U Nigwekar
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

7.  Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine.

Authors:  Masato Nishimura; Toshiko Tokoro; Toru Takatani; Nodoka Sato; Masaya Nishida; Tetsuya Hashimoto; Satoru Yamazaki; Hiroyuki Kobayashi; Toshihiko Ono
Journal:  Springerplus       Date:  2015-07-16

8.  Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.

Authors:  Terumi Higuchi; Masanori Abe; Toshio Yamazaki; Mari Mizuno; Erina Okawa; Hideyuki Ando; Osamu Oikawa; Kazuyoshi Okada; Fumito Kikuchi; Masayoshi Soma
Journal:  Nutrients       Date:  2014-12-22       Impact factor: 5.717

9.  Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis.

Authors:  Masako Kuwasawa-Iwasaki; Hiroaki Io; Masahiro Muto; Saki Ichikawa; Keiichi Wakabayashi; Reo Kanda; Junichiro Nakata; Nao Nohara; Yasuhiko Tomino; Yusuke Suzuki
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

Review 10.  Significance of Levocarnitine Treatment in Dialysis Patients.

Authors:  Hiroyuki Takashima; Takashi Maruyama; Masanori Abe
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.